Wade G W & Inc Verve Therapeutics, Inc. Transaction History
Wade G W & Inc
- $3.08 Billion
- Q4 2023
A detailed history of Wade G W & Inc transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Wade G W & Inc holds 259,626 shares of VERV stock, worth $2.89 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
259,626
Previous 259,626
-0.0%
Holding current value
$2.89 Million
Previous $3.44 Million
5.11%
% of portfolio
0.12%
Previous 0.13%
Shares
3 transactions
Others Institutions Holding VERV
# of Institutions
26Shares Held
8.54MCall Options Held
31.4KPut Options Held
122K-
Black Rock Inc. New York, NY6.62MShares$73.7 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL1.32MShares$14.6 Million0.0% of portfolio
-
Xtx Topco LTD London, X0125KShares$1.39 Million0.08% of portfolio
-
Credit Suisse Ag Zurich, V865.7KShares$731,7080.0% of portfolio
-
Greenland Capital Management LP New York, NY49.5KShares$551,0010.06% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $667M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...